CH311608A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents

Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Info

Publication number
CH311608A
CH311608A CH311608DA CH311608A CH 311608 A CH311608 A CH 311608A CH 311608D A CH311608D A CH 311608DA CH 311608 A CH311608 A CH 311608A
Authority
CH
Switzerland
Prior art keywords
methyl
anilide
chloro
ethylamine
fatty acid
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Cilag
Original Assignee
Cilag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag filed Critical Cilag Ag
Publication of CH311608A publication Critical patent/CH311608A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

       

  



  Verfahren zur Herstellung eines neuen basisch substituierten   Fettsäure-       (2-halogen-6-methyl-anilids).   



   Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch   substituierten Fettsäure- (2-halogen-6-      methyl-a, nilids), welches dadureh gekennzeich-    net ist, dass man eine Verbindung der Formel
EMI1.1     
 in weleher   Xeinenreaktionsfähigen,während    der Reaktion sich   abspaltenden    Rest bedeutet, mit ¯thylamin umsetzt.



   Der Rest X kann in einem Ha. logenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer   Alkylsul-      fonyloxy-oder      Arylsulfonyloxygruppe,    bestehen. Der Austausch der Gruppe X gegen den erfolgt z. B. durch einfaches Erwärmen mit Äthylamin gegebenenfalls in Gegenwart eines basisch reagierenden Konden  sationsmittels    oder von   Äthylamin    im   tuber-      sehuss.    Das ¯thylaminoacet-(2-chlor-6-methyl  anilid)    ist ein farbloses, unter 0, 03 mm Hg bei 140-142  siedendes Íl. Das   Hydroehlorid    der Base schmilzt bei   267-270 .   



   Das neue Anilid soll als LokalanÏsthetikum und als Zwischenprodukt zur Herstellmg weiterer Derivate Verwendung finden.



   Beispiel :
36 Gewichtsteile   Chloracet-      (2-chlor-6-me-      thyl-anilid)    (gewonnen diurch Umsetzen von   2-Chlor-6-methyl-anilin    mit   Chloraeetylchlorid    in Gegenwart von Natriumacetat, Schmp. 140 bis   141 )    werden in 200 Gewichtsteilen    70''/oiger wässriger Äthylaminlosung suspen-    diert. Die Temperatur steigt dabei leieht an, und ein grosser Teil des Reaktionsgemisehes geht in   Losung.    Nun wird während 4 Stunden in geschlossenem Gefäss bei Zimmertemperatur   geriihrt    und dann einige Stunden bei 100 bis 110¯.

   Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt, ergibt wieder Lösung des   ausgefallenen Niedersehlages.   



  Mit Wasserdampf wird hierauf das   überschüs-      sige Äthylamin    abgeblasen und nach dem Erkalten und SÏttigen mit Kochsalz das zurüekbleibende   01    in Äther aufgenommen. Nach dem Trocknen der ätherischen Lösung und   Verjagen    des Lösungsmittels verbleibt ein Íl, das durch Vakuumdestillation gereinigt wird.



  Man erhält 31 Gewichtsteile reines ¯thyl  aminoacet-      (2-chlor-6-methyl-anilid).    Die Umsetzung mit   Äthylamin    kann auch in Benzol stattfinden.  



   PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6   methyl-anilids), dadurch gekennzeichnet, dass    man eine Verbindung der Formel 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).



   The subject matter of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl-a, nilide), which is characterized by the fact that a compound of the formula
EMI1.1
 in which X a reactive radical which is split off during the reaction means, reacts with ¯thylamine.



   The rest of X can be in a Ha. logenatom or another suitable for the exchange against the basic radical reactive substituents such. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against takes place z. B. by simply heating with ethylamine, optionally in the presence of a basic reacting condensation agent or ethylamine in tuber- sehuss. The ¯thylaminoacet- (2-chloro-6-methyl anilide) is a colorless oil that boils below 0.03 mm Hg at 140-142. The hydrochloride of the base melts at 267-270.



   The new anilide is to be used as a local anesthetic and as an intermediate for the production of further derivatives.



   Example:
36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroetyl chloride in the presence of sodium acetate, melting point 140 to 141) are added in 200 parts by weight 70 ' '/ o aqueous ethylamine solution suspended. The temperature rises, and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours in a closed vessel at room temperature and then for a few hours at 100 to 110 °.

   A sample with water and then mixed with dilute hydrochloric acid again results in a solution of the precipitated deposit.



  The excess ethylamine is then blown off with steam and, after cooling and saturation with table salt, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation.



  31 parts by weight of pure ethyl aminoacet- (2-chloro-6-methyl-anilide) are obtained. The reaction with ethylamine can also take place in benzene.



   PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula

** WARNING ** End of DESC field could overlap beginning of CLMS **.




    

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids). Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-a, nilids), welches dadureh gekennzeich- net ist, dass man eine Verbindung der Formel EMI1.1 in weleher Xeinenreaktionsfähigen,während der Reaktion sich abspaltenden Rest bedeutet, mit ¯thylamin umsetzt. The subject matter of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl-a, nilide), which is characterized by the fact that a compound of the formula EMI1.1 in which X is a reactive residue that is split off during the reaction and reacts with ¯thylamine. Der Rest X kann in einem Ha. logenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsul- fonyloxy-oder Arylsulfonyloxygruppe, bestehen. Der Austausch der Gruppe X gegen den erfolgt z. B. durch einfaches Erwärmen mit Äthylamin gegebenenfalls in Gegenwart eines basisch reagierenden Konden sationsmittels oder von Äthylamin im tuber- sehuss. Das ¯thylaminoacet-(2-chlor-6-methyl anilid) ist ein farbloses, unter 0, 03 mm Hg bei 140-142 siedendes Íl. Das Hydroehlorid der Base schmilzt bei 267-270 . The rest of X can be in a Ha. logenatom or another suitable for the exchange against the basic radical reactive substituents such. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against takes place z. B. by simply heating with ethylamine, optionally in the presence of a basic reacting condensation agent or ethylamine in tuber- sehuss. The ¯thylaminoacet- (2-chloro-6-methyl anilide) is a colorless oil that boils below 0.03 mm Hg at 140-142. The hydrochloride of the base melts at 267-270. Das neue Anilid soll als LokalanÏsthetikum und als Zwischenprodukt zur Herstellmg weiterer Derivate Verwendung finden. The new anilide is to be used as a local anesthetic and as an intermediate for the production of further derivatives. Beispiel : 36 Gewichtsteile Chloracet- (2-chlor-6-me- thyl-anilid) (gewonnen diurch Umsetzen von 2-Chlor-6-methyl-anilin mit Chloraeetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 200 Gewichtsteilen 70''/oiger wässriger Äthylaminlosung suspen- diert. Die Temperatur steigt dabei leieht an, und ein grosser Teil des Reaktionsgemisehes geht in Losung. Nun wird während 4 Stunden in geschlossenem Gefäss bei Zimmertemperatur geriihrt und dann einige Stunden bei 100 bis 110¯. Example: 36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroetyl chloride in the presence of sodium acetate, melting point 140 to 141) are added in 200 parts by weight 70 ' '/ o aqueous ethylamine solution suspended. The temperature rises, and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours in a closed vessel at room temperature and then for a few hours at 100 to 110 °. Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt, ergibt wieder Lösung des ausgefallenen Niedersehlages. A sample with water and then mixed with dilute hydrochloric acid again results in a solution of the precipitated deposit. Mit Wasserdampf wird hierauf das überschüs- sige Äthylamin abgeblasen und nach dem Erkalten und SÏttigen mit Kochsalz das zurüekbleibende 01 in Äther aufgenommen. Nach dem Trocknen der ätherischen Lösung und Verjagen des Lösungsmittels verbleibt ein Íl, das durch Vakuumdestillation gereinigt wird. The excess ethylamine is then blown off with steam and, after cooling and saturation with table salt, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation. Man erhält 31 Gewichtsteile reines ¯thyl aminoacet- (2-chlor-6-methyl-anilid). Die Umsetzung mit Äthylamin kann auch in Benzol stattfinden. 31 parts by weight of pure ethyl aminoacet- (2-chloro-6-methyl-anilide) are obtained. The reaction with ethylamine can also take place in benzene. PATENTANSPRUCH : Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6 methyl-anilids), dadurch gekennzeichnet, dass man eine Verbindung der Formel EMI2.1 in welcher X einen reaktionsfähigen, während der Reaktion sieh abspaltenden Rest bedeutet, mit Äthylamin umsetzt. Das auf diese Weise erhaltene Äthylaminoacet- (2-chlor-6-methyl- anilid) bildet ein farbloses, mter 0, 03 mm Hg bei 140-142¯ siedendes Íl. Das Hydroehlorid der Base schmilzt bei 267-270¯ Das neue Anilid soll als LokalanÏsthetikum und als Zwischenprodukt Verwendung finden. PATENT CLAIM: Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula EMI2.1 in which X denotes a reactive radical which is split off during the reaction, with ethylamine. The ethylaminoacet- (2-chloro-6-methyl-anilide) obtained in this way forms a colorless, 0.3 mm Hg at 140-142¯ boiling oil. The hydrochloride of the base melts at 267-270¯ The new anilide is to be used as a local anÏesthetic and as an intermediate product. UNTERANSPR. UCH : Verfahren nach Patentanspruch, dadurch gkennzeichnet, dass man ein Halogenaeet- (2- chlor-6-methyl-anilid) mit ¯thylamin reagieren lϯt. SUB-CLAIM UCH: Process according to patent claim, characterized in that a halogenate (2-chloro-6-methyl-anilide) is allowed to react with ¯thylamine.
CH311608D 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). CH311608A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311608T 1952-02-25
CH307799T 1952-11-25

Publications (1)

Publication Number Publication Date
CH311608A true CH311608A (en) 1955-11-30

Family

ID=25735341

Family Applications (1)

Application Number Title Priority Date Filing Date
CH311608D CH311608A (en) 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Country Status (1)

Country Link
CH (1) CH311608A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11643404B2 (en) 2019-03-11 2023-05-09 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US11603355B2 (en) 2019-03-11 2023-03-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11512058B2 (en) 2019-03-11 2022-11-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11696912B2 (en) 2019-11-06 2023-07-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Similar Documents

Publication Publication Date Title
CH311608A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311613A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311606A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311610A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311609A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311614A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311607A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311612A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311615A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311644A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311604A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311629A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311630A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311642A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311603A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311605A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311621A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311631A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311632A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311639A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311624A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311620A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311622A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH312572A (en) Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide
CH311616A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).